TRPV4 is necessary for trigeminal irritant pain and functions as a cellular formalin receptor-Reference-Cited by-同舟云学术

TRPV4 is necessary for trigeminal irritant pain and functions as a cellular formalin receptor

Published:2014-12 Issue:12 Volume:155 Page:2662-2672
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Chen Yong,Kanju Patrick,Fang Quan,Lee Suk Hee,Parekh Puja K.,Lee Whasil,Moore Carlene,Brenner Daniel,Gereau Robert W.,Wang Fan,Liedtke Wolfgang

Funder

NIH

Duke Institute for Brain Science (DIBS)

Leon Goldberg Fellowship (Nicholas School for the Environment, Duke University)

Minority Supplement

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference41 articles.

1. Hypotonicity induces TRPV4-mediated nociception in rat.;Alessandri-Haber;Neuron,2003

2. Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury.;Alvarez;Circ Res,2006

3. Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases.;Bessac;FASEB J,2009

4. Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat.;Birder;J Pharmacol Exp Ther,2007

5. Peripheral purinergic receptor modulation influences the trigeminal ganglia nitroxidergic system in an experimental murine model of inflammatory orofacial pain.;Borsani;J Neurosci Res,2010

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zusätzliche Erfahrungen mit medikamentöser Therapie von Trigeminalschmerzen;Der Schmerz;2024-08-14

2. Targeting TRPV4 Channels for Cancer Pain Relief;Cancers;2024-04-27

3. ATF4 inhibits TRPV4 function and controls itch perception in rodents and nonhuman primates;Pain;2024-02-28

4. TRP channels as potential target molecules for pharmacotherapy of neurological diseases;TRP Channels as Therapeutic Targets;2024

5. TRPV4-Rho GTPase complex structures reveal mechanisms of gating and disease;Nature Communications;2023-06-23